-
JW Partners' Jason Wild Talks Cannabis, TerrAscend, Stock Picks With Barron's
Tuesday, October 13, 2020 - 11:37am | 555Jason Wild, CEO of JW Asset Management LLC, is one of the most seasoned U.S. institutional investors in legal cannabis. The former pharmacist, who oversees $1 billion in assets, recently chatted with Barron's about his fund. "From 1998 to 2010...
-
Arbor Pharma Announces Acquisition Of Xenoport At A 60% Premium
Monday, May 23, 2016 - 9:26am | 339Shares of XenoPort, Inc. (NASDAQ: XNPT), a small-cap bio-pharmaceutical company that focuses on the commercializing HORIZANT in the United States for the treatment of adults with moderate to severe primary Restless Legs Syndrome, surged higher by nearly 60 percent early Monday morning. XenoPort...